Literature DB >> 4367701

Myasthenia gravis.

W K Engel, B W Festoff, B M Patten, M L Swerdlow, H H Newball, M D Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4367701     DOI： 10.7326/0003-4819-81-2-225

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Juvenile myasthenia: diagnosis and treatment.

Authors:  B Anlar
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 3.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

4.  A membrane-associated autoantibody in a case of myasthenia gravis with chronic hepatitis.

Authors:  A J Fairfax; D Doniach; C E Wells
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

5.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  [Myasthenia gravis in a young dog (author's transl)].

Authors:  L Breton; Y Gosselin; L Couture
Journal:  Can Vet J       Date:  1981-10       Impact factor: 1.008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.